Skip to main content
. 2022 Jan 14;12:794780. doi: 10.3389/fimmu.2021.794780

Table 2.

The ES, vdW and covalent interactions of inhibitor N3, psilacetin, psilocin, and psilocybine with SARS-CoV-2 Mprotease.

S. No. Protein Inhibitors ES interactions vdW interactions Covalent bonds Binding affinity (kcal/mol)
1. Mprotease N3 His163, His164, Phe140, Gly143, Glu166, His172, Gln189, Thr190, and Ala191 Thr26, His41, Thr24, Thr25, Met49, Ser144, Cys145, Leu141, Asn142, Asp187, Gln192, Met165, and Pro168 Cys145
2. Mprotease Psilacetin His41, Tyr54, Glu166, Asp187 and Thr190 Met49, His164, Met165, Ley167, Pro168, Arg188, Gln198, Gln192 -6.0
3. Mprotease Psilocin His41, Leu141, Cys145, His163, Gly143, Ser144, and Gln189 Thr25, Thr26, Leu27, Asn142, Met165, Phe140, Glu166, and His172 -5.4
4. Mprotease Psilocybine His41, Asn142, Phe140, Leu141, Gly143, His163, Ser144, Cys145, Met165, His164, and Gln189 Thr25, Thr26, Leu27, Met49, Glu166, and His172 -5.8
5. HIK-6 NAG, BMA, MAN, NDG Asn110, Glu144, Gln147, Gln158, and Asn226, Ser109, Val112, Pro145, and Ser227 Asn226
6. HIK-6 Psilacetin Ser106, Asn110, Gln158, Ser224, and Asn226 Phe103, Lys105, Ser109, and Val112 -4.1